Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
Status:
Withdrawn
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This prospective study will determine the pharmacokinetic parameters of citalopram in 12
adult patients with short bowel syndrome. While data on the prevalence of depression in
patients with short bowel syndrome is sparse, the investigators' experience is that these
patients have a high incidence of depression and should benefit from a psychopharmacological
intervention.